Nerve damage classified as a central-peripheral distal axonopathy is produc
ed by a variety of chemicals (e.g. acrylamide, n-hexane). Historically, axo
n swelling and secondary degeneration have been considered the morphologic
hallmarks of toxic axonopathies and substantial research has been devoted t
oward deciphering corresponding molecular mechanisms. However, recent studi
es from the author's laboratory investigating rate (mg toxicant/kg/day) and
route (i.p. vs gavage) of intoxication have shown that swelling and degene
ration were related to neurotoxicant dosing conditions (i.e. low-dose, subc
hronic exposure) and not to development of neurophysiological deficits or c
lassic behavioral toxicity. This suggests the presumed hallmarks of distal
axonopathy are epiphenomena of uncertain pathophysiologic significance. The
refore, the current definition of and chemical classification scheme for to
xic distal axonopathies requires re-evaluation. (C) 2000 Elsevier Science I
reland Ltd. All rights reserved.